Detalhe da pesquisa
1.
AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance.
J Biol Chem
; 285(1): 115-22, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19892703
2.
Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity.
J Biol Chem
; 285(48): 37198-209, 2010 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20855892
3.
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity.
Hepatology
; 52(5): 1632-42, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20799351
4.
Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation.
Am J Physiol Endocrinol Metab
; 297(1): E57-66, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19435854
5.
Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice.
J Steroid Biochem Mol Biol
; 170: 39-48, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27353462
6.
Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice.
PLoS One
; 10(8): e0136143, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317527
7.
Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.
PLoS One
; 9(2): e87230, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24520329
8.
Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity.
Diabetes
; 62(1): 56-64, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22961088
9.
Antibody therapeutics - the evolving patent landscape.
N Biotechnol
; 28(5): 538-44, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21515427
10.
Macrophage deletion of SOCS1 increases sensitivity to LPS and palmitic acid and results in systemic inflammation and hepatic insulin resistance.
Diabetes
; 60(8): 2023-31, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21646388
11.
Hematopoietic AMPK ß1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity.
J Clin Invest
; 121(12): 4903-15, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22080866
12.
Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes.
Chem Biol
; 15(11): 1220-30, 2008 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19022182